HIV types, groups, subtypes and recombinant forms: Errors in replication, selection pressure and quasispecies

Intervirology

Volumn 55, Issue 2, 2012, Pages 79-83

  Eberle, Josef ^a   Gürtler, Lutz ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

AIDS; Genetic factors; HIV; Quasispecies; Selection pressure

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; HLA B27 ANTIGEN; HLA B57 ANTIGEN; LANGERIN; REV PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRANSACTIVATOR PROTEIN; VIF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; DISEASE TRANSMISSION; FOLLOW UP; HEREDITY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNE SYSTEM; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SUPERINFECTION; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; RECOMBINATION, GENETIC; SELECTION, GENETIC; VIRUS REPLICATION;

CERCOCEBUS TORQUATUS ATYS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PAN;

EID: 84856416239     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000331993     Document Type: Article

References (41)

1. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T: Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288:1789-1796.
2. Neel C, Etienne L, Li Y, Takehisa J, Rudicell RS, Bass IN, Moudindo J, Mebenga A, Esteban A, van Heuerswyn F, Liegeois F, Kranzusch PJ, Walsh P-grave, Sanz CM, Morgan DB, Ndjango JBN, Plantier JC, Locatelli S, Gonder MK, Leendertz FH, Boesch C, Todd A, Delaporte E, Mpoudi-Ngole E, Hahn BH, Peeters M: Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol 2010;84:1464-1476.
3. Etienne L, Nerrienet E, Le Breton M, Bibila GT, Foupouapouognigni Y, Rousset D, Nana A, Djoko CF, Tamoufe U, Aghokeng AF, Mpoudi-Ngole E, Delaporte E, Peeters M, Wolfe N-grave, Ayouba A: Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AI-graveS related symptoms. Retrovirology 2011;8:4.
4. Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J, Harris B, Holzmayer V, Luk KC, Schochetman G, Swanson P, Yamaguchi J, Vallari A, Ndembi N, Ngansop C, Makamche F, Mbanya D, Gürtler LG, Zekeng L, Kaptue L: The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr 2008;49:432-439.
5. UNAI-graveS/WHO. http://www.who.int/hiv/pub/epidemiology/pubfacts.
6. Fultz PN, McClure HM, Anderson DC, Swenson RB, Anand R, Srinivasan A: Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci USA 1986;83:5286-5290.
7. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM: Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003;100:6588-6592.
8. Burgard M, Jasseron C, Matheron S, Damond F, Hamrene K, Blanche S, Faye A, Rouzioux C, Warszawski J, Madelbrot L: Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ARNS French Perinatal Cohort EPF-CO1. Clin Infect Dis 2010;51:833-843.
9. Tienen C, van der Loeff MS, Zaman SM, Vincent T, Sarge-Njie R, Peterson I, Leliqdowicz A, Jave A, Rowland-Jones S, Aaby P, Whittle H: Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. J Acquir Immune Defic Syndr 2010;53:640-647.
10. Gunthard HF, Huber M, Kuster H, Shah C, Schüppach J, Trkola A, Böni J: HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clin Infect Dis 2009;48:e117-e120.
11. Iordanskiy S, Wattke M, Feng Y, Wood C: Subtype-associated differences in the HIV-1 reverse transcription affect the viral replication. Retrovirology 2010;7:85.
12. Pathak VK, Temin HW: Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci USA 1990;87:6019-6023.
13. Pathak VK, Temin HM: Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci USA 1990;87:6024-6028.
14. Alvarez M, Matamoros T, Menendez-Arias L: Increased thermostability and fidelity of DNA synthesis of wild-type and mutant HIV-1 group O reverse transcriptases. J Mol Biol 2009;392:872-884.
15. Shimizu N, Okamoto T. Moriyama EN, Takeuchi Y, Gojobori T, Hoshino H: Patterns of nucleotide substitutions and implications for the immunological diversity of human immunodeficiency virus. FEBS Lett 1989;250:591-595.
16. Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomom H: Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol 2002;76:7000-7009.
17. Buzon MJ, Wrin T, Codoner FM, Dalmau J, Phung P, Bonjoch A, Coakley E, Clotet B, Martinez-Picado J: Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes. J Acquir Immune Defic Syndr 2011;57:109-117.
18. Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L: Evidence for human immunodeficiency virus type 1 replication in vivo in C-grave14+ monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002;76:707-716.
19. Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, Clarke DK, Moya A, Elena SF, de la Torre JC, Holland JJ: RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis 1994;3:201-214.
20. Law M, Murayama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR: Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 2008;14:25-27.
21. Onafuwa-Nuga A, Telesnitzky A: The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev 2009;73:451-480.
22. Simon-Loriere E, Martin DP, Weeks KM, Negroni M: RNA structures facilitate recombinationmediated gene swapping in HIV-1. J Virol 2010;84:12675-12682.
23. Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O, Burger H: Recombination following superinfection by HIV-1. AI-graveS 2004;18:153-159.
24. Kuiken C, Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Wolinsky S, Korber B (eds): HIV Sequence Compendium. Los Alamos National Laboratory, Los Alamos, 2009 http://www.hiv. lanl.gov/.
25. Motomura K, Chen J, Hu WS: Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses. J Virol 2008;82:1923-1933.
26. Domingo E: Mechanism of viral emergence. Vet Res 2010;41:38-52.
27. Dai L, Stevenson M: A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol 2010;84:8327-8331.
28. Bocharov G, Ford NJ, Edwards J, Breinig T, Wain-Hobson S, Meyerhans A: A geneticalgorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiple infected cells and recombination. J Gen Virol 2005;86:3109-3118.
29. Van der Kuyl AC, Kozacynska K, van den Burg R, Zorgdrager F, Back N, Juriaans S, Berkhout B, Reiss P, Cornelissen M: Triple HIV-1 infection. N Engl J Med 2005;352:2557-2559.
30. Batmanian J, Brew BJ: Clinical significance of central nervous system as sanctuary site for HIV. J HIV Ther 2005;10:16-21.
31. Dahl V, Josefsson L, Palmer S: HIV reservoirs, latency and reactivation: prospects for eradication. Antiviral Res 2010;85:286-294.
32. Smith DM, Wong JK, Hightower GK, Ignacio C, Koelsch KK, Petropoulos CJ, Richman D-grave, Little SJ: HIV drug resistance acquired through superinfection. AI-graveS 2005;19:1251-1256.
33. Rachinger A, Stolte IG, van de Ven T-grave, Burger JA, Prins M, Suitemaker H, van' t Wout AB: Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behaviour in the seroincident Amsterdam Cohort of homosexual men. Clin Infect Dis 2010;50:1309-1315.
34. Lorenzo-Redondo R, Borderia AV, Lopez-Galindez C: Dynamics of in vitro fitness recovery of HIV-1. J Virol 2011;85:1384-1390.
35. Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R: Tumultous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol Mol Biol Rev 2009;73:211-232.
36. Van der Vlist M, Geijtenbeek TB: Langerin functions as an antiviral receptor on Langerhans cells. Immunol Cell Biol 2010;88:410-415.
37. Sauter D, Specht A, Kirchhoff F: Tetherin. Holding on and letting go. Cell 2010;141:392-398.
38. Sterjovski J, Churchill MJ, Roche M, Ellett A, Farrugia W, Wesselingh SL, Cunnigham AL, Ramsland PA, Gorry PR: C-grave4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-C-grave4 interactions and fusogenicity. Virology 2011;410:418-428.
39. Swenson LC, Mo T, Dong WW, Zhong X, Woods CK, Jensen MA, Thielen A, Chapman D, Lewis M, James I, Heera J, Valdez H, Harrigan PR: Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. J Infect Dis 2011;203:237-245.
40. * 1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis 2011;203:803-809.
41. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, Van Manen D, Bream JH, Gomperts E-grave, Buchbinder S, Goedert JJ, Kirk G-grave, O'Brien SJ: Genome-wide association study implicates PAR-grave3B-based AI-graveS restriction. J Infect Dis 2011;203:1491-1502.